- Home
- IMNN vs ILAG Comparison
IMNN vs ILAG Comparison
Compare IMNN & ILAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- ILAG
- Stock Information
- Founded
- IMNN 1982
- ILAG 1981
- Country
- IMNN United States
- ILAG Hong Kong
- Employees
- IMNN N/A
- ILAG N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- ILAG Office Equipment/Supplies/Services
- Sector
- IMNN Health Care
- ILAG Consumer Discretionary
- Exchange
- IMNN Nasdaq
- ILAG Nasdaq
- Market Cap
- IMNN 12.1M
- ILAG 10.7M
- IPO Year
- IMNN 1985
- ILAG 2022
- Fundamental
- Price
- IMNN $6.53
- ILAG $0.55
- Analyst Decision
- IMNN Buy
- ILAG
- Analyst Count
- IMNN 2
- ILAG 0
- Target Price
- IMNN $182.61
- ILAG N/A
- AVG Volume (30 Days)
- IMNN 244.8K
- ILAG 250.7K
- Earning Date
- IMNN 08-05-2025
- ILAG 04-28-2025
- Dividend Yield
- IMNN N/A
- ILAG N/A
- EPS Growth
- IMNN N/A
- ILAG N/A
- EPS
- IMNN N/A
- ILAG N/A
- Revenue
- IMNN N/A
- ILAG $7,506,551.00
- Revenue This Year
- IMNN N/A
- ILAG N/A
- Revenue Next Year
- IMNN N/A
- ILAG N/A
- P/E Ratio
- IMNN N/A
- ILAG N/A
- Revenue Growth
- IMNN N/A
- ILAG 16.50
- 52 Week Low
- IMNN $4.83
- ILAG $0.34
- 52 Week High
- IMNN $41.22
- ILAG $1.35
- Technical
- Relative Strength Index (RSI)
- IMNN 40.89
- ILAG 56.14
- Support Level
- IMNN $6.17
- ILAG $0.50
- Resistance Level
- IMNN $7.21
- ILAG $0.60
- Average True Range (ATR)
- IMNN 0.51
- ILAG 0.05
- MACD
- IMNN 0.14
- ILAG 0.00
- Stochastic Oscillator
- IMNN 20.45
- ILAG 41.14
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About ILAG Intelligent Living Application Group Inc.
Intelligent Living Application Group Inc focuses on designing and producing affordable, high-quality locksets and smart security systems. The company offers high-quality mechanical locksets and smart locks to its customers. Its product portfolio comprises various ODM indoor and outdoor locksets, such as deadbolts, entry locksets, privacy locksets, passage locksets, and storeroom locks, which are marketed through brands like Kambo and Bamberg. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada.